Integrating liquid biopsies in non-small cell lung cancer diagnosis and management: opportunities and challenges

While significant progress has been made integrating liquid biopsies in NSCLC, challenges persist, encompassing issues of standardization, cost, and clinical integration.

Authors

Institutions

Publication Details

Journal
Expert Review of Anticancer Therapy
Published
2026-02-09
DOI
https://doi.org/10.1080/14737140.2026.2630026
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Integrating liquid biopsies in non-small cell lung cancer diagnosis and management: opportunities and challenges

Y. Oya, Kenneth Sooi, Rui Fu, Y. Ang et al.
Expert Review of Anticancer Therapy
Lung Cancer Treatments and Mutations
article

Integrating liquid biopsies in non-small cell lung cancer diagnosis and management: opportunities and challenges

Y. Oya, Kenneth Sooi, Rui Fu, Y. Ang, Jeong Uk Lim, Ross A. Soo
article en

Abstract

While significant progress has been made integrating liquid biopsies in NSCLC, challenges persist, encompassing issues of standardization, cost, and clinical integration.

Expert Review of Anticancer Therapy
Fujita Health University (JP), National Cancer Institute (MY), Southern Medical University (CN), Catholic University of Korea (KR)
Good health and well-being
Openalex Percentile: Top 65%
Lung Cancer Treatments and Mutations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.